Cigna Corporation

(New York Stock Exchange)

Top News rankings and signal summaries are processed using AI and may contain errors.

1
Bullish +75

Cigna Earnings Call Highlights Growth, EPS Upgrade

AI-generated analysis

Cigna (CI) reported its Q1 2026 earnings results on May 1, highlighting strong revenue growth, a raised full-year earnings per share outlook, and momentum in its core healthcare and specialty businesses. The company posted consolidated revenue of $68.5 billion for the quarter, with adjusted EPS...

Bullish Signals

  • Cigna reported Q1 2026 revenue of $68.5B and adjusted EPS of $7.79.
  • Evernorth revenues climbed 9% YoY to $58.4B driven by platform uptake.
  • Specialty earnings grew 20% YoY to $1.1B highlighting higher-margin offerings.
  • Cigna Healthcare earnings rose 18% reflecting disciplined underwriting and cost management.
  • Medical care ratio improved to 79.8%, beating expectations with seasonal cushion.
  • Prior authorization volume dropped 15% by removing hundreds of U.S. tests.
  • J.D. Power ranks Cigna first in digital experience satisfaction second year.
  • 'Signature' pharmacy model offers brand drugs at prices about 30% lower.
  • High-cost claimant model generates around $2,000 annual savings per engaged member.
  • Digital tools cut inbound calls by 20% for U.S. employer customers.
  • PBM members drove a 25% decline in inbound calls supporting lower costs.

Bearish Signals

  • $322M Q1 special charges weighed on reported earnings.
  • P&S adjusted earnings fell 28% YoY due to renewals.
  • Exit of individual exchange may trim near-term revenue.
  • EviCore strategic review creates segment performance uncertainty.
  • Noncontrolling interest doubled to $226M adding modeling complexity.
2
Very Bullish +85

Cigna: Q1 Earnings Snapshot

AI-generated analysis

Cigna Corp. (CI) reported first-quarter earnings of $1.18 billion, translating to a profit of $3.68 per share. On an adjusted basis that excludes non-recurring costs and amortization, the company achieved $6.01 per share in earnings. These financial results significantly exceeded Wall Street expectations. Analysts surveyed...

Bullish Signals

  • Q1 earnings of $1.18B and EPS of $6.01 beat expectations.
  • Revenue of $44.01B exceeded analyst forecasts.
  • Full-year guidance: $22.60 EPS and $177B revenue.
3
Bullish +75

The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook

AI-generated analysis

The Cigna Group reported strong financial results for the first quarter of 2026, driven by a diversified portfolio that included growth across its healthcare services and pharmacy benefit segments. Total revenues for the quarter increased 5% year-over-year to reach $68.5 billion, compared to the previous...

Bullish Signals

  • Total Q1 2026 revenue rose 5% to $68.5B.
  • Net income per share grew significantly to $1.7 billion.
  • Adjusted operating income surged 12% to $2.1 billion.
  • Full-year adjusted income outlook raised to at least $30.35.
  • Operational efficiency improved as SG&A ratio declined to 4.8%.
  • Debt-to-capitalization ratio dropped to 42.3% for stronger balance sheet.

Bearish Signals

  • Pharmacy Benefit Services pre-tax income dropped 28% in Q1 2026.
  • Total customer relationships fell 2% to 185.5 million by March 2026.
  • Revolving HCSC transaction partially offset total revenue growth.
  • Core high-margin segment faces significant performance headwinds.
4
Very Bullish +80

Cigna Earnings Call Highlights Growth, EPS Upgrade

AI-generated analysis

Cigna Group (CI) reported strong first-quarter 2026 results, delivering consolidated revenue of $68.5 billion and adjusted EPS of $7.79, which reflects a 16% year-over-year increase. On the back of this performance, management raised its full-year 2026 adjusted EPS guidance to at least $30.35 per share....

Bullish Signals

  • Cigna Q1 2026 revenue hit $68.5 billion with 16% EPS growth.
  • Full-year 2026 adjusted EPS guidance raised to at least $30.35.
  • Evernorth revenues climbed 9% YoY to $58.4 billion via platform uptake.
  • Specialty earnings grew 20% YoY, while Healthcare medical ratio hit 79.8%.
  • Cigna ranked #1 in J.D. Power digital satisfaction for second year.
  • New pharmacy model offers brand drugs at 30% lower prices.
  • A.I. tools cut inbound calls by 20% and PBM calls by 25%.
  • Operating cash flow reached $1.1 billion, supporting dividends and debt reduction.
  • Company guiding to further leverage reduction by year-end 2026.

Bearish Signals

  • Pharmacy benefit services earnings fell 28% year-over-year to $394 million.
  • Special items charges of $322 million hurt reported earnings.
  • Individual exchange exit and eviCore review will trim near-term revenue.
  • Noncontrolling interest doubled to $226 million due to a new joint venture.
5
Bullish +65

The Cigna Group stock gains focus as 2026 earnings outlook rises

Earnings report Guidance raised Share buyback AI-generated analysis

The Cigna Group reported a stronger third-quarter performance, with revenue rising 6 percent year over year to $73.7 billion for the three months ended September 30. Adjusted earnings from operations reached $2.1 billion, or $7.98 per share, driven by improved efficiency and higher net investment...

Bullish Signals

  • EPS outlook raised to $30.60 for 2026.
  • Q3 revenue grew 6% YoY to $73.7B.
  • Healthcare pretax income rose 15% to $1.2B.
  • Repurchased 1.8M shares for ~$500M.
  • Medical care ratio expectation narrowed to 84.2%.

Bearish Signals

  • Net income dropped $1.4B vs $1.9B due to missing gain.
  • Evernorth PBM earnings fell amid renewals and investments.
6
Bullish +65

Cigna boosts 2026 outlook as insurance, specialty pharmacy profits climb

Company update Earnings report Guidance raised AI-generated analysis

Cigna Group (CI) reported a strong third quarter with net income of $1.4 billion on revenue of $73.7 billion, beating analyst expectations. While year-over-year net income declined to $1.9 billion from the prior year, adjusted earnings per share and adjusted operating income both increased, reflecting...

Bullish Signals

  • Cigna raised 2026 adjusted income outlook to $30.60 per share.

Bearish Signals

  • Express Scripts operating income declined 22% YoY during transition.
7
Bullish +75

Cigna launches Health Sense: Piper targets Cigna Group stock at USD 370

Company update Product launch AI-generated analysis

Cigna Group has launched Health Sense, a personalized care model designed to reduce inefficient healthcare spending by 10% by 2030. The initiative, which targets oncology and cardiometabolic conditions, is scheduled to begin operations in early 2027. This strategic launch follows strong financial performance in the...

Bullish Signals

  • Revenue rose 7% YoY to $71.7B in Q2 2026.
8
Bullish +65

Cigna Group stock holds steady as earnings beat and 2026 guidance support valuation

AI-generated analysis

Cigna Group reported quarterly earnings of $7.78 per share on July 30, 2026, beating the consensus estimate of $7.60. The company generated revenue of $70.04 billion for the quarter, representing a 6.7% increase year-over-year, though this figure was marginally below analyst expectations of $70.14 billion....

Bullish Signals

  • Cigna Group beat quarterly earnings expectations with EPS of $7.78 versus the consensus estimate of $7.60.
  • The company reaffirmed its fiscal 2026 EPS guidance at $30.45, which is broadly in line with analyst forecasts, providing strong earnings visibility.
  • Cigna Group maintains a sustainable dividend payout ratio of approximately 25.82% while returning cash via a quarterly dividend of $1.56 per share.
  • Analysts see significant upside potential as the current stock price of $282.24 is well below the consensus price target of $339.45.

Bearish Signals

  • Cigna Group's quarterly revenue of $70.04 billion was marginally below analyst expectations of $70.14 billion.
  • The company operates with relatively thin net margins of 2.27%, making it sensitive to shifts in medical cost trends, pricing, or utilization rates.
9
Bullish +65

As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit

AI-generated analysis

The Cigna Group reported robust second-quarter financial results under new CEO Brian Evanko, posting net income of nearly $1.7 billion ($6.29 per share) and a 7% revenue increase to $71.7 billion. This performance marks the first quarterly report since Evanko took over from David Cordani...

Bullish Signals

  • Net income rose to $1.66 billion.
  • 2026 earnings guidance raised to $30.45 per share.
  • Revenue increased 7% to $71.7 billion.
  • Medical cost ratio of 84.5% beats competitors above 90%.
  • Growth driven by Cigna Healthcare and Evernorth Health Services.

Bearish Signals

  • Medical cost ratio rose to 84.5% from 83.2%.
  • Elevated medical expenses continue to pressure results.
10
Bullish +65

Folger Nolan Fleming Douglas Capital Management Inc. Purchases New ...

AI-generated analysis

Folger Nolan Fleming Douglas Capital Management Inc. acquired a new position in Cigna Group (NYSE:CI) during the first quarter, purchasing 3,521 shares valued at approximately $939,000. Other institutional investors also adjusted their stakes, with Brighton Jones LLC increasing its position by 9.3% to own 3,736...

Bullish Signals

  • EPS beat at $7.79 vs $7.60 consensus.
  • Revenue hit $68.52B, up 4.6% year-over-year.
  • UBS raised target to $400 with 'buy' rating.
  • Major brokers maintain buy/outperform ratings above current levels.
  • Full-year 2026 EPS guidance aligns with forecasts.
  • Healthy 2.2% dividend yield with 26.45% payout ratio.

Bearish Signals

  • CEO sold 201,878 shares ($59.1M), ownership down 85.46%.
  • CAO sold 899 shares ($268,450), holdings down 27.52%.
11
Bullish +75

Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends - 24/7 Wall St.

AI-generated analysis

Health insurers rallied on Thursday afternoon following a wave of bullish analyst notes highlighting softer medical cost trends and potential AI efficiency gains in the managed-care sector. Humana led the advance with a 6% jump to $348, while UnitedHealth Group rose 5% to $396 and...

Bullish Signals

  • AI efficiencies could unlock 45% average EPS growth.
  • Bank of America upgraded stock to Buy with $450 target.
  • Humana gained 37% this month and 28% year-to-date.
  • Q1 2026 adjusted earnings of $7.23 beat estimates.
  • Medical cost ratio improved to 84%, up 90 bps.

Bearish Signals

  • Stock down 10% over past year and 2% YTD.
  • Uncertainty on utilization trends moderating into second quarter.
  • Q2 2026 earnings setup is next major margin test.
  • Traders selective until momentum builds for laggard stock.
12
Bullish +75

Cigna Q1 Earnings Beat Estimates on Strong Evernorth Unit

AI-generated analysis

Cigna Group (CI) reported first-quarter 2026 results that exceeded analyst expectations, driven primarily by strong performance from its Evernorth Health Services segment. The company posted adjusted earnings per share of $7.79, surpassing the Zacks Consensus Estimate by 2.2%, with total adjusted EPS growth of 15.6%...

Bullish Signals

  • Cigna earnings beat estimates with Q1 EPS at $7.79.
  • Revenues grew 4.7% YoY reaching $68.5 billion.
  • Medical customers hit 18.3 million beating consensus.
  • Operating income rose 12% to $2.1 billion.
  • SG&A ratio improved 100 bps to 4.8%.
  • Evernorth revenues surged 9% YoY to $58.4 billion.
  • Cigna Healthcare income climbed 18% to $1.5 billion.
  • MCR improved 240 bps to 79.8%.
  • Guidance raised with 2026 EPS min at $30.35.
  • Operating income forecasts lifted for Evernorth and Healthcare.

Bearish Signals

  • Cash reserves fell 8.3% to $7 billion.
  • Total assets contracted 2.9% to $153.3 billion.
  • Operating cash flow plunged 41% to $1.1 billion.
  • HCSC transaction caused Cigna Healthcare revenue drop of 21%.
  • Evernorth margins deteriorated 20 bps to 2.5%.
13
Somewhat Bullish +45

[CI] Cigna: Q3 2026 Earnings Test Whether Pharmacy Benefit Profit Has ...

Company update Earnings report AI-generated analysis

Cigna Group (NYSE: CI) reported Q2 2026 results with adjusted EPS of $7.78, marking an 8% increase year-over-year despite a 27% decline in Pharmacy Benefit Services profit. The company is now preparing to report Q3 2026 earnings on November 5, 2026, which will be critical...

Bullish Signals

  • Cigna Healthcare profit grew 17% to $1.276B in Q2.

Bearish Signals

  • P&L profit declined 27% due to concessions and Signature model spending.
14
Bullish +75

Cigna Group stock pre-market at EUR 241.80: plus 1.13 percent

Company update Financial outlook AI-generated analysis

Cigna Group stock is trading at EUR 241.80 in pre-market sessions, representing a gain of 1.13% against the prior close of EUR 239.10 recorded on October 2, 2026. The current market activity shows a bid of EUR 239.90 and an ask of EUR 243.70, with...

Bullish Signals

  • Revenue projected at $280B for 2026.
  • EPS growth target of 10-14% CAGR to 2030.
  • Announced $3B investment in modernization initiative.
  • Projects $50B cumulative operating cash flow 2026-2030.
15
Bullish +65

CVS vs Cigna: Which Healthcare Giant Belongs in Your Retirement Portfolio?

AI-generated analysis

This article compares CVS Health (NYSE: CVS) and Cigna Group (NYSE: CI) as potential holdings for retirement portfolios, highlighting that both are currently trading at historically low valuations. Cigna is noted for being cheaper on key metrics, trading at approximately 9.4x trailing adjusted earnings compared...

Bullish Signals

  • Net income surged 73.47% YoY to $5.957B in FY2025.
  • Beat adjusted EPS estimates in all four quarters of 2025.
  • Evernorth Health Services achieved 17% revenue growth in Q4 2025.
  • Repurchased 11.9 million shares for $3.6 billion during 2025.
  • SG&A ratio improved to 5.0% from 5.9% year-over-year.

Bearish Signals

  • Trades at 9.3x vs CVS's 10.7x, limiting upside if healthcare re-rates.
16
Somewhat Bullish +45

Cigna Group $CI Shares Sold by Allspring Global Investments Holdings ...

AI-generated analysis

Allspring Global Investments Holdings LLC significantly reduced its stake in Cigna Group (CI) by 66.3% in the first quarter, selling 185,718 shares and retaining a position worth approximately $25.3 million. While Allspring exited substantially, other institutional investors like apricus wealth LLC, Wealth Enhancement Advisory Services...

Bullish Signals

  • Beat EPS estimates at $7.79 vs $7.60 consensus.
  • Revenue grew 4.6% YoY to $68.52 billion.
  • Bernstein raised target to $381 with 'outperform' rating.
  • Raymond James set bullish $340 price target.
  • Healthy 2.2% dividend yield with 26.45% payout ratio.

Bearish Signals

  • Barclays downgraded stock from 'overweight' to 'equal weight'.
  • CEO sold 201,878 shares worth over $59 million.
17
Bullish +65

Cigna Group $CI Shares Sold by California Public Employees Retirement ...

AI-generated analysis

California Public Employees Retirement System (CalPERS) reduced its stake in Cigna Group by 7.6% in the first quarter, selling 46,513 shares and holding approximately 0.22% of the company worth $151.7 million. While CalPERS exited a significant portion of its position, several smaller institutional investors and...

Bullish Signals

  • EPS beat estimates at $7.79 vs $7.60 consensus.
  • Revenue grew 4.6% YoY to $68.52 billion.
  • Net margin of 2.26% and ROE of 19.75%.
  • Bernstein raised target to $381 with 'outperform' rating.
  • Cantor lifted target to $340 with 'overweight' rating.

Bearish Signals

  • CEO David Cordani sold 200,000 shares for $59 million.
  • CFO Jamie G. Kates decreased stake by 27.5%.
18
Bullish +65

1,964 Shares in Cigna Group $CI Bought by Ascentis Independent Advisors

AI-generated analysis

Ascentis Independent Advisors purchased a new stake in Cigna Group (NYSE:CI) totaling 1,964 shares valued at approximately $524,000 during the first quarter. Several other institutional investors also adjusted their positions in the fourth quarter, with Cary Street Partners increasing its stake by 11.0% to own...

Bullish Signals

  • EPS beat estimates at $7.79 vs $7.60 consensus.
  • Revenue reached $68.52B, beating $66.29B estimate.
  • Mizuho raised target to $340 with outperform rating.
  • Morgan Stanley raised target to $361 with overweight.
  • Net margin hit 2.26% and ROE was 19.75%.
  • Dividend yield stands at 2.2% annually.
  • Revenue grew 4.6% year-over-year.

Bearish Signals

  • CEO sold 201,878 shares for $59.1M, dropping ownership 85.46%.
  • CAO sold 899 shares for $268k, reducing stake 27.52%.
19
Bullish +75

The Cigna Group (CI) Stock Analysis: Uncovering A Promising 21.93% Upside Potential - DirectorsTalk Interviews

AI-generated analysis

The Cigna Group (NYSE: CI) is a major player in the healthcare sector with a market capitalization of $73.88 billion. Currently trading at $279.27, the stock has dipped slightly but maintains resilience within its 52-week range of $244.41 to $334.39. Analysts project an average target...

Bullish Signals

  • Analysts target $340.50, implying 21.93% upside.
  • ROE stands at 16.27% with 4.60% revenue growth.
  • Free cash flow reaches $6.92 billion.
  • 20 of 24 analysts rate it a buy.
  • Forward P/E is 8.35, suggesting undervaluation.
  • Dividend yield is 2.23% with a 24.36% payout ratio.
20
Somewhat Bearish -25

The Cigna Group: Client Retention Matters, But Contract Profitability Matters More

Analyst downgrade AI-generated analysis

The Cigna Group (CI) has been downgraded from a Buy to a Hold rating with a new target price of $318, which reflects a limited 4.1% upside potential. This shift in analyst sentiment comes despite the company's manageable debt levels and steady dividend payments, as...

Bullish Signals

  • Debt levels remain manageable for stable operations.
  • Steady dividends signal strong cash flow confidence.

Bearish Signals

  • PBM margins pressured by offsetting specialty drug revenue growth.
  • Signature model transition adds costs and competitive pricing headwinds.
  • Employer fee demands constrain future margin expansion potential.
  • Slowed share buybacks reduce shareholder value creation driver.